Skip to main content
. 2016 Nov 4;129(3):358–370. doi: 10.1182/blood-2016-06-719237

Table 1.

NrasG12D/+p53−/− MEPs are transformed to leukemia-initiating cells

Donor cell types No. of donor cells No. of helper cells No. of recipient mice Disease diagnosis No. of diseased animals %
WBM 2.5 × 105 2.5 × 105 20 AML and T-ALL 20 100
CD45+ BM 2.5 × 105 2.5 × 105 4 AML and T-ALL 4 100
HSC 30 2 × 105 10 AML and T-ALL 7 70
MPP 30 2 × 105 12 AML and T-ALL 10 83
MP 10 000 2 × 105 15 AML 8 53
GMP 4000 2 × 105 8 N/A 0 0
MEP 2000 2 × 105 14 AML 10 71

Primary NrasG12D/+p53−/− mice were injected with pI-pC as described in “Materials and methods.” Various types of cells were isolated on day 12 and transplanted with helper cells (CD45.1+) into lethally irradiated mice. Mice without any diseases were monitored for at least 200 days.

BM, bone marrow; WBM, whole bone marrow.